BFB759

TypeNot recorded StagePhase 2 Latest updateJul 15, 2025Phase 2 study started

What stands out

Human mAb

Derived from NCT07105488 · This is a summary of public records for informational purposes only. It is not medical advice.

History

Earliest recorded event: Jul 15, 2025. This timeline shows events collected by Eczema Radar and may not include the treatment’s full history. Study details reflect the latest registry record available here.

Jul 15, 2025Phase 2 trial startedA Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis ClinicalTrials.gov NCT07105488

Sources

Trials

COMPASS 2-AD · NCT07105488